Product Program year 2023 Source: CMS Open Payments

Oravig

Drug Antifungal

NDC 61825-303-14

Open in the dashboard

General payments

$18,797

56 payments

Research payments

$0

0 payments

Through program year 2023, $18,797 in general payments and $0 in research payments were reported against Oravig (Antifungal).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2023 General $18,797 56

Breakdown

Who paid General payments · program year 2023
  1. Galt Pharmaceuticals, LLC $18,797 56 payments
Top recipients General payments · program year 2023
  1. Vishala Chindalore Rheumatology · Anniston, AL $1,471 8% · 2 payments
  2. Johnny Young Anniston, AL $1,453 8% · 1 payment
  3. Aasim Sehbai Hematology & Oncology · Anniston, AL $1,125 6% · 2 payments
  4. Wesley Sherrell Dentist, Oral and Maxillofacial Surgery · Duluth, GA $1,037 6% · 3 payments
  5. Ruwanthi Campano Otolaryngology · Palmdale, CA $1,000 5% · 1 payment

The top 5 of 52 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Nurse Practitioner, Family Nurse Practitioner $4,486 26% · 10 practitioners
  2. Otolaryngology $2,300 14% · 4 practitioners
  3. Dentist, Oral and Maxillofacial Surgery Dentist $1,637 10% · 3 practitioners
  4. Rheumatology Internal Medicine $1,471 9% · 1 practitioner
  5. Dentist $1,300 8% · 3 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. Alabama $11,105 59% · 28 recipients
  2. California $2,000 11% · 3 recipients
  3. Georgia $1,086 6% · 2 recipients
  4. Florida $1,000 5% · 2 recipients
  5. Hawaii $907 5% · 8 recipients

The top 5 of 12 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

56 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record